1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US and Europe Surrogacy Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US and Europe Surrogacy Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. US and Europe Surrogacy Market Regional Analysis
6.1 US and Europe Surrogacy Market Overview
6.2 US and Europe Surrogacy Market Revenue 2020-2030 (US$ Million)
6.3 US and Europe Surrogacy Market Forecast Analysis
7. US and Europe Surrogacy Market Analysis – by Type
7.1 Gestational Surrogacy
- 7.1.1 Overview
- 7.1.2 Gestational Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Traditional Surrogacy
- 7.2.1 Overview
- 7.2.2 Traditional Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2031 (US$ Million)
8. US and Europe Surrogacy Market Analysis – by Technology
8.1 Intrauterine Insemination
- 8.1.1 Overview
- 8.1.2 Intrauterine Insemination: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
8.2 In-vitro Fertilization
- 8.2.1 Overview
- 8.2.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9. US and Europe Surrogacy Market Analysis – by Age Group
9.1 Below 35 years
- 9.1.1 Overview
- 9.1.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.2 35-37 years
- 9.2.1 Overview
- 9.2.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 38-39 years
- 9.3.1 Overview
- 9.3.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 40-42 years
- 9.4.1 Overview
- 9.4.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.5 43-44 years
- 9.5.1 Overview
- 9.5.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Over 44 years
- 9.6.1 Overview
- 9.6.2 In-vitro Fertilization: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
10. US and Europe Surrogacy Market – United State Analysis
10.1 Asia-Pacific
- 10.1.1 US and Europe Surrogacy Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 US and Europe Surrogacy Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 China:
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 China: US and Europe Surrogacy Market Breakdown, by Type
- 10.1.1.1.2 China: US and Europe Surrogacy Market Breakdown, by Technology
- 10.1.1.1.3 China: US and Europe Surrogacy Market Breakdown, by Age Group
- 10.1.1.2 India:
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 India: US and Europe Surrogacy Market Breakdown, by Type
- 10.1.1.2.2 India: US and Europe Surrogacy Market Breakdown, by Technology
- 10.1.1.2.3 India: US and Europe Surrogacy Market Breakdown, by Age Group
- 10.1.1.3 Japan:
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Japan: US and Europe Surrogacy Market Breakdown, by Type
- 10.1.1.3.2 Japan: US and Europe Surrogacy Market Breakdown, by Technology
- 10.1.1.3.3 Japan: US and Europe Surrogacy Market Breakdown, by Age Group
- 10.1.1.4 Australia:
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Australia: US and Europe Surrogacy Market Breakdown, by Type
- 10.1.1.4.2 Australia: US and Europe Surrogacy Market Breakdown, by Technology
- 10.1.1.4.3 Australia: US and Europe Surrogacy Market Breakdown, by Age Group
- 10.1.1.5 Rest of Asia-Pacific :
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Rest of Asia-Pacific : US and Europe Surrogacy Market Breakdown, by Type
- 10.1.1.5.2 Rest of Asia-Pacific : US and Europe Surrogacy Market Breakdown, by Technology
- 10.1.1.5.3 Rest of Asia-Pacific : US and Europe Surrogacy Market Breakdown, by Age Group
10.2 United State
- 10.2.1 US and Europe Surrogacy Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 US and Europe Surrogacy Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 United State:
US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 United State: US and Europe Surrogacy Market Breakdown, by Type
- 10.2.1.1.2 United State: US and Europe Surrogacy Market Breakdown, by Technology
- 10.2.1.1.3 United State: US and Europe Surrogacy Market Breakdown, by Age Group
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. US and Europe Surrogacy Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 London Women's Clinic Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 The Centre for Reproductive and Genetic Health Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Miracle Baby Surrogacy
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Lotus Surrogacy
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 VittoriaVita LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Sensible Surrogacy
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New Life Ukraine
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Redia Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Circle Surrogacy LLC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Ovation Fertility
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For US and Europe Surrogacy Market
